Merck KGaA (MKKGY) Expected to Announce Quarterly Earnings on Thursday

Merck KGaA (OTCMKTS:MKKGY) is anticipated to post its results before the market opens on Thursday, March 5th. Analysts expect Merck KGaA to post earnings of $0.47 per share and revenue of $6.2030 billion for the quarter.

Merck KGaA Stock Up 0.7%

Shares of OTCMKTS:MKKGY opened at $29.90 on Thursday. The company has a market capitalization of $19.32 billion, a PE ratio of 11.91, a price-to-earnings-growth ratio of 6.01 and a beta of 0.96. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 0.97. The business has a fifty day moving average price of $29.56 and a two-hundred day moving average price of $27.51. Merck KGaA has a 1 year low of $24.32 and a 1 year high of $31.00.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft lowered shares of Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.